BENDER LEWIS H
SEC insider (Form 3/4/5 filer). CIK 0001238705. President and CEO at INTENSITY THERAPEUTICS, INC. (INTS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in SHELTON, CT.
Companies BENDER LEWIS H has filed insider reports for
- INTENSITY THERAPEUTICS, INC. (INTS): Director, Officer, President and CEO
BENDER LEWIS H
CIK: 0001238705
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INTENSITY THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 16, 2026INTS
INTENSITY THERAPEUTICS, INC.
AwardDirectStock Option (right to buy Common Stock)
78K shares- - Mar 26, 2026INTS
INTENSITY THERAPEUTICS, INC.
AwardDirect37.7K shares at avg. $6.11$231K - May 2, 2025INTS
INTENSITY THERAPEUTICS, INC.
AwardDirectStock Option (right to buy Common Stock)
700K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 | INTS INTENSITY THERAPEUTICS, INC. | Award Stock Option (right to buy Common Stock) | 78,000 | - | - | Direct |
| Mar 26, 2026 | INTS INTENSITY THERAPEUTICS, INC. | Award | 37,749 | $6.11 | $230,646 | Direct |
| May 2, 2025 | INTS INTENSITY THERAPEUTICS, INC. | Award Stock Option (right to buy Common Stock) | 700,000 | - | - | Direct |
1-3 of 3 transactions